A battery of cognitive and affective tests administered to 50
consecutively admitted medical oncology patients revealed cognitive
impairment to be a common occurrence in the absence of affective disorders
or other psychopathology. Chemotherapy was the major variable associated
with cognitive impairment in these patients. These findings suggest that
the consultant psychiatrist should be aware of chemotherapy as a possible
source of behavioral change and emotional distress in cancer patients.Abstract Teaser